Creative Capital Management Investments’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$52.1K Buy
104
+16
+18% +$7.68K 0.01% 163
2026
Q1
$43.3K Hold
88
0.01% 122
2025
Q4
$51K Hold
88
0.02% 117
2025
Q3
$42.7K Hold
88
0.01% 120
2025
Q2
$35.7K Hold
88
0.01% 135
2025
Q1
$43.8K Hold
88
0.02% 115
2024
Q4
$45.8K Sell
88
-30
-25% -$16.5K 0.02% 105
2024
Q3
$73K Buy
118
+88
+293% +$52.1K 0.03% 83
2024
Q2
$16.6K Buy
30
+1
+3% +$573 0.01% 138
2024
Q1
$16.9K Hold
29
0.01% 132
2023
Q4
$15.4K Hold
29
0.01% 133
2023
Q3
$14.7K Hold
29
0.01% 137
2023
Q2
$15.1K Hold
29
0.01% 130
2023
Q1
$16.7K Buy
29
+25
+625% +$14.1K 0.01% 136
2022
Q4
$2K Buy
+4
New +$2.12K ﹤0.01% 179

Other funds holding TMO

Creative Capital Management Investments's TMO Position: Q2 2026 in Review

Creative Capital Management Investments increased its Thermo Fisher Scientific (TMO) stake by 18% in Q2 2026, buying an estimated $7.68K and bringing the position to 104 shares worth $52.1K. The position accounts for 0.01% of the portfolio, ranked #163.

Creative Capital Management Investments first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. The position peaked at $73K in Q3 2024. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Creative Capital Management Investments held 104 shares of Thermo Fisher Scientific worth $52.1K as of Q2 2026.
  • Creative Capital Management Investments bought 16 Thermo Fisher Scientific shares in Q2 2026, an estimated $7.68K.
  • Thermo Fisher Scientific made up 0.01% of Creative Capital Management Investments's portfolio in Q2 2026, its #163 holding.
  • Creative Capital Management Investments first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
  • Creative Capital Management Investments's Thermo Fisher Scientific position peaked at $73K in Q3 2024.
  • 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Creative Capital Management Investments's 13F filing for Q2 2026, filed 24 Jul 2026.